Study of Zoledronic Acid Administered Monthly Versus Every 3 Months in Multiple Myeloma and Breast Cancer Patients Who Were Treated With Zoledronic Acid the Prior Year
- Status
- COMPLETED
- Phase
- PHASE1
Related studies linked through entity extraction aliases.